The instructions for Abbott's Amplatzer Amulet Left Atrial Appendage Occluder now include more details about minimizing the risk of pulmonary artery injury. This a Class II recall, but no devices need to be returned.

AI has made a significant impact on the way clinicians use CCTA. For example, what were once time-consuming manual measurements are now performed automatically in the blink of an eye. 

The American College of Cardiology is pointing to the importance of prescribing exercise to heart patients. "Small increases in physical activity can produce meaningful benefits, particularly for those who are currently inactive," one expert explained. 

California-based Masimo received the clearance just a few months after being acquired by Danaher Corporation in a deal worth approximately $9.9 billion.

Survey data will be used in advocacy efforts with employers and policymakers to advance key safety initiatives.

Cardiac surgeon compensation is up 11%, according to new survey data from MedAxiom and the American College of Cardiology. Vascular surgeons experienced an increase in pay as well, but it was much smaller.

Certain Sapien M3 TMVR delivery systems have been linked to a risk of malfunctioning in a way that puts patients at risk. The devices included in this early alert should be returned to the manufacturer. 

A new FDA-approved pulmonary valve should reduce the number of open-heart surgeries children with congenital heart disease require as they grow older. Emile Bacha, MD, explained the importance of this device in a new video interview. 

Overall, more than 950,000 clinicians submitted queries to a popular AI platform from January 2024 to June 2026. Cardiovascular care was a common topic, especially questions about specific treatments and medications. 

This update comes just months after 11,000 bottles of the same drug were recalled due to a failed test. The FDA has classified this as a Class II recall. 

According to new data from SullivanCotter, compensation in the United States is up more than 20% in the last five years for interventional cardiology, electrophysiology, general cardiology and vascular surgery. This points to a workforce that is getting more competitive over time, one expert told Cardiovascular Business.

The 50-page document outlines what the FDA would like to see as vendors submit their technologies for regulatory review. It covers robotic systems of all types, including those used for various cardiac procedures. 

Released Friday, the proposed rule is designed to comply with an act of Congress passed in February. Changes include regular audit requirements for Medicare Advantage coverage networks and enhanced reporting for pharmacy benefit managers.

The scam resulted in Medicare paying out more than $3 million for back and knee braces that doctors never prescribed and patients did not need, the U.S. Department of Justice said.